PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -37.2% | 14,050 | -3.4% | 0.04% | +24.1% |
| Q1 2022 | $43,000 | -44.2% | 14,550 | -6.4% | 0.03% | +31.8% |
| Q3 2021 | $77,000 | -39.4% | 15,550 | -20.5% | 0.02% | -57.7% |
| Q2 2021 | $127,000 | -8.0% | 19,550 | 0.0% | 0.05% | +20.9% |
| Q1 2021 | $138,000 | 0.0% | 19,550 | -11.3% | 0.04% | -27.1% |
| Q4 2020 | $138,000 | +1.5% | 22,050 | -10.2% | 0.06% | -3.3% |
| Q3 2020 | $136,000 | +4.6% | 24,550 | -2.0% | 0.06% | +10.9% |
| Q2 2020 | $130,000 | +66.7% | 25,050 | 0.0% | 0.06% | +57.1% |
| Q1 2020 | $78,000 | -22.0% | 25,050 | 0.0% | 0.04% | -2.8% |
| Q4 2019 | $100,000 | -6.5% | 25,050 | 0.0% | 0.04% | -16.3% |
| Q3 2019 | $107,000 | -10.1% | 25,050 | -16.6% | 0.04% | -20.4% |
| Q2 2019 | $119,000 | -16.2% | 30,050 | +13.1% | 0.05% | -41.3% |
| Q1 2019 | $142,000 | -11.2% | 26,567 | +8.7% | 0.09% | +17.9% |
| Q4 2018 | $160,000 | +39.1% | 24,450 | +81.8% | 0.08% | +25.8% |
| Q3 2018 | $115,000 | – | 13,450 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|